Harpreet Singh of the FDA discusses how clinical trial populations are not always reflective of the population of patients who eventually end up getting treated by the therapies.
Harpreet Singh
Advertisement
Articles by Harpreet Singh
Advertisement
Latest Updated Articles
Harpreet Singh on Clinical Trial Eligibility in the Elderly Cancer PopulationPublished: July 12th 2016 | Updated:
Advertisement
Advertisement
